Sign up to save your podcasts
Or
Share March 2025: The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
March 2025: The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials
Dr. William Horan (Bristol Myers Squibb) joins AJP Audio to discuss a newly approved, novel treatment for schizophrenia spectrum disorder, which has potential impacts for cognition in patients. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin puts the rest of the March issue into context.
- 00:45 Horan interview
- 03:15 Novel mechanism of action in the treatment of schizophrenia
- 05:39 Side effect profiles
- 07:20 Clinical impacts
- 08:31 The need for further investigation
- 09:58 Limitations
- 11:05 Further research
- 13:08 Kalin interview
- 13:21 Horan et al.
- 17:34 Levenstein et al.
- 19:00 Fountoulakis et al.
- 20:57 Couture et al.
- 23:18 Stern et al.
- 27:35 McGirr et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
View all episodes
By American Journal of Psychiatry
3.9
7373 ratings
Dr. William Horan (Bristol Myers Squibb) joins AJP Audio to discuss a newly approved, novel treatment for schizophrenia spectrum disorder, which has potential impacts for cognition in patients. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin puts the rest of the March issue into context.
- 00:45 Horan interview
- 03:15 Novel mechanism of action in the treatment of schizophrenia
- 05:39 Side effect profiles
- 07:20 Clinical impacts
- 08:31 The need for further investigation
- 09:58 Limitations
- 11:05 Further research
- 13:08 Kalin interview
- 13:21 Horan et al.
- 17:34 Levenstein et al.
- 19:00 Fountoulakis et al.
- 20:57 Couture et al.
- 23:18 Stern et al.
- 27:35 McGirr et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
More shows like American Journal of Psychiatry Audio
View all
Neurology® Podcast
288 Listeners
NEI Podcast
137 Listeners
Journal of the American Academy of Child and Adolescent Psychiatry
27 Listeners
Practical Neurology Podcast
48 Listeners
Core EM - Emergency Medicine Podcast
247 Listeners
JAMA Psychiatry Author Interviews
21 Listeners
Psychiatric Services From Pages to Practice
26 Listeners
Psychiatry & Psychotherapy Podcast
1,316 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
716 Listeners
Psychopharmacology and Psychiatry Updates
289 Listeners
Psychoanalysis On and Off the Couch
157 Listeners
The Carlat Psychiatry Podcast
563 Listeners
The Curbsiders Addiction Medicine Podcast
120 Listeners
Psychiatry Boot Camp
176 Listeners
PsychRounds: The Psychiatry Podcast
113 Listeners